Observational Study to Assess Natural History in Cockayne Syndrome Patients
NCT00985413 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2011-06-23
Summary
This is an Observational Study of children under the age of 11 diagnosed with Cockayne Syndrome to assess the natural progression of Cockayne Syndrome disease, with special attention to hearing and physical changes in length or height, weight, head circumference, and arm span during standard treatment.
The primary analytical objective is to determine the rate of linear growth over a 6-month period in children \< 2 years of age and over a 12-month period in children ≥ 2 years of age.
Conditions
- Cockayne Syndrome
Sponsors & Collaborators
-
DNage B.V.
lead INDUSTRY
Principal Investigators
-
E. G. Neilan, MD, PhD · Boston Children's Hospital
Eligibility
- Min Age
- 1 Year
- Max Age
- 11 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2011-02-28
- Completion
- 2011-02-28
Countries
- United States
- France
- United Kingdom
Study Locations
More Related Trials
-
Study of Skeletal Disorders and Short Stature
NCT00001754 ·Status: COMPLETED
-
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513 ·Status: COMPLETED
-
Testing the Feasibility of a Novel Growth Monitoring Smartphone App
NCT05829252 ·Status: COMPLETED
-
C-Type Natriuretic Peptide and Achondroplasia
NCT01541306 ·Status: COMPLETED
-
A Pharmaco-epidemiological Study of Short Patients Born Small for Gestational Age (SGA), Treated With Saizen® (Recombinant Somatropin)
NCT01082354 ·Status: COMPLETED
-
Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome
NCT00266656 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study of Somatropin Treatment in Children
NCT01088412 ·Status: COMPLETED
-
The Effect of Growth Hormone in Very Young Girls With Turner Syndrome
NCT00406926 ·Status: COMPLETED ·Phase: PHASE3
-
Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy
NCT00625872 ·Status: TERMINATED ·Phase: PHASE3
-
Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy
NCT00174291 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 ·Status: TERMINATED
-
Lifetime Impact of Achondroplasia Study in Europe-LIAISE
NCT03449368 ·Status: COMPLETED
-
A Multicenter, Multinational Clinical Assessment Study for Pediatric Patients With Achondroplasia
NCT01603095 ·Status: COMPLETED
-
Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
NCT01066052 ·Status: COMPLETED ·Phase: PHASE4
-
Achondroplasia Natural History Multicenter Clinical Study
NCT02597881 ·Status: RECRUITING
-
Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
NCT00742157 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Assess Growth in Children With Idiopathic Short Stature
NCT06309979 ·Status: RECRUITING
-
A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
NCT06668805 ·Status: RECRUITING ·Phase: PHASE2
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment Patterns and Treatment Outcomes for Acromegaly
NCT03043586 ·Status: COMPLETED
-
The Treatment and Natural History of Acromegaly
NCT00001981 ·Status: COMPLETED
-
Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients
NCT05858606 ·Status: RECRUITING ·Phase: NA
-
Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®
NCT01187550 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
NCT00234533 ·Status: COMPLETED ·Phase: PHASE3
-
Natural History Study of Patients With Excess Androgen
NCT00250159 ·Status: RECRUITING